• 제목/요약/키워드: R&BD

검색결과 358건 처리시간 0.03초

파력발전 시스템 쓰러스트 베어링의 스마트 모니터링을 위한 이상 및 고장 운용 재현 방법에 관한 연구 (A Study on the Abnormal and Fault Reproduction Method for Smart Monitoring of Thrust Bearing in Wave Power Generation System)

  • 오재원;민천홍;성기영;강관구;노현정;김태욱;조수길
    • 한국산업융합학회 논문집
    • /
    • 제23권5호
    • /
    • pp.835-842
    • /
    • 2020
  • This paper considers a method of reproducing abnormal and fault operation for smart monitoring of thrust bearing used in wave power generation system. In order to develop smart monitoring technology, abnormal and failure data of actual equipment are required. However, it is impossible to artificially break down the actual equipment in operation due to safety and cost. To tackle this problem, a test bed that can secure data through reproduction of a faulty operating environment should be developed. Therefore, in this study, test bed that can reproduce each situation was developed and the operation result was analysis after identifying the situation to be reproduced through the failure factor analysis of the thrust bearing.

BD 기록기를 위한 전단 시스템에 관한 연구 (A Study of Front-end System for BD Recorder)

  • 최광석
    • 대한전자공학회논문지SD
    • /
    • 제44권6호
    • /
    • pp.28-33
    • /
    • 2007
  • BD-R/RE/ROM을 2배속으로 기록하고 재생할 수 있는 전단 시스템을 개발하였다. 시스템의 재생능력은 PR(a,b,c,d,e)형 5탭 PRML을 채택함으로써 향상되었다. 제안된 PRML덕분에 2배속 25GB 디스크에서 ${\mp}0.6{\circ}$ 이상의 라디알 및 탄젠셜 틸드 마진을 가지고도 $2{\times}10^{-4}$이하의 BER을 얻을 수 있었다. 최적파워레벨이 다른 다양한 BD-R/RE의 안정적인 기록을 위해 OPC 방법에 대해서도 제안하였다. 개발한 시스템은 $0.18-{\mu}m$ CMOS공정으로 $60mm^2$ 면적에 1,400만 트랜지스터를 칩에 집적하였다.

기술이전 및 사업화 활성화를 위한 전략 도출 프레임워크 - R&BD 효율성 평가를 기반으로 - (The Framework for the Strategy of Research & Business Development)

  • 김준영;성시일;박재훈
    • 품질경영학회지
    • /
    • 제44권4호
    • /
    • pp.785-798
    • /
    • 2016
  • Purpose: This paper developed the framework for extracting strategies of research and business development (R&BD) based on the data envelopment analysis(DEA). Methods: DEA has been widely utilized in evaluating R&D efficiency. Even though, technology transfer and commercialization has been regarded as the important factors for practical R&D efficiency evaluation, most research have evaluated R&D efficiency by just using the DEA outputs such as the number of patents and papers. The technology transfer, commercialization and relations among costs and generated technology and commercialization are needed to be considered for more practical R&D efficiency evaluation. Thus, this research addressed a method on how to incorporate the commercialization factors into the R&DB efficiency evaluation, and improve the efficiency strategically in terms of R&D and B&D. To achieve this, this research utilized a two-stage network DEA model for R&BD efficiency evaluation. Results: The proposed framework was applied to the 15 public research institutes and the 34 universities for validation. R&BD efficiency for the 15 public research institutes and the 34 universities was evaluated, and the differentiated improvement strategies for the inefficient DMUs to improve their efficient were proposed. Conclusion: The R&BD efficiency would be effectively analyzed based on two-stage network DEA. It would be utilized for the effective strategy planning for cultivating R&BD.

Potential of Lilium lancifolium in Alleviating Pain and Inflammation in a Rat Model of Monosodium Iodoacetate-Induced Osteoarthritis

  • Kim, Jisoo;Kim, Joo Yun;Jeong, Ji-Woong;Choi, Il dong;Park, Soo-Dong;Lee, Jung Lyoul;Sim, Jae-Hun
    • 한국자원식물학회지
    • /
    • 제33권6호
    • /
    • pp.638-644
    • /
    • 2020
  • Lilium lancifolium (LL) is widely cultivated in East Asia and used to attenuate airway diseases. Our current study aimed to investigate the therapeutic effect of LL on pain level and inflammatory response in a rat model of monosodium iodoacetate (MIA)-induced osteoarthritis (OA). We first examined the effect of LL on inflammatory cytokines and inflammatory mediators in IL-1β-treated HTB-94 cells. The LL extract was found to significantly inhibit the levels of Interleukin-6 (IL-6), Interleukin-8 (IL-8), and prostaglandin-E2 (PGE-2) in Interleukin-1 β (IL-1β)-stimulated HTB-94 cells in a dose-dependent manner. Moreover, chronic oral administration of LL effectively restored the weight-bearing distribution in the rat model of MIA-induced OA. In addition, administration of LL inhibited inflammatory cytokines and inflammatory mediators, such as C-reactive protein (CRP), IL-6, leukotriene B4 (LTB-4), PGE-2, and matrix metalloproteinase-9 (MMP-9). Our findings collectively suggested LL as one of the potential therapeutic agents for OA, owing to its properties of reducing pain and inflammatory responses.

Selection of Lactococcus lactis HY7803 for Glutamic Acid Production Based on Comparative Genomic Analysis

  • Lee, Jungmin;Heo, Sojeong;Choi, Jihoon;Kim, Minsoo;Pyo, Eunji;Lee, Myounghee;Shin, Sangick;Lee, Jaehwan;Sim, Jaehun;Jeong, Do-Won
    • Journal of Microbiology and Biotechnology
    • /
    • 제31권2호
    • /
    • pp.298-303
    • /
    • 2021
  • Comparative genomic analysis was performed on eight species of lactic acid bacteria (LAB)-Lactococcus (L.) lactis, Lactobacillus (Lb.) plantarum, Lb. casei, Lb. brevis, Leuconostoc (Leu.) mesenteroides, Lb. fermentum, Lb. buchneri, and Lb. curvatus-to assess their glutamic acid production pathways. Glutamic acid is important for umami taste in foods. The only genes for glutamic acid production identified in the eight LAB were for conversion from glutamine in L. lactis and Leu. mesenteroides, and from glucose via citrate in L. lactis. Thus, L. lactis was considered to be potentially the best of the species for glutamic acid production. By biochemical analyses, L. lactis HY7803 was selected for glutamic acid production from among 17 L. lactis strains. Strain HY7803 produced 83.16 pmol/μl glutamic acid from glucose, and exogenous supplementation of citrate increased this to 108.42 pmol/μl. Including glutamic acid, strain HY7803 produced more of 10 free amino acids than L. lactis reference strains IL1403 and ATCC 7962 in the presence of exogenous citrate. The differences in the amino acid profiles of the strains were illuminated by principal component analysis. Our results indicate that L. lactis HY7803 may be a good starter strain for glutamic acid production.

Immunostimulatory effects of dairy probiotic strains Bifidobacterium animalis ssp. lactis HY8002 and Lactobacillus plantarum HY7717

  • Ju-Yeon, Kim;Joo Yun, Kim;Hyeonji, Kim;Eun Chae, Moon;Keon, Heo;Jae-Jung, Shim;Jung-Lyoul, Lee
    • Journal of Animal Science and Technology
    • /
    • 제64권6호
    • /
    • pp.1117-1131
    • /
    • 2022
  • Previous studies reported that Bifidobacterium animalis ssp. lactis HY8002 (HY8002) improved intestinal integrity and had immunomodulatory effects. Lactobacillus plantarum HY7717 (HY7717) was screened in vitro from among 21 other lactic acid bacteria (LAB) and demonstrated nitric oxide (NO) production. The aims of this study were to investigate the individual and combined ex vivo and in vivo effects of LAB strains HY8002 and HY7717 at immunostimulating mice that have been challenged with an immunosuppressant drug. The combination of HY8002 and HY7717 increased the secretion of cytokines such as interferon (IFN)-γ, interleukin (IL)-12, and tumor necrosis factor (TNF)-α in splenocytes. In a cyclophosphamide (CTX)-induced immunosuppression model, administration of the foregoing LAB combination improved the splenic and hematological indices, activated natural killer (NK) cells, and up-regulated plasma immunoglobulins and cytokines. Moreover, this combination treatment increased Toll-like receptor 2 (TLR2) expression. The ability of the combination treatment to upregulate IFN-γ and TNF-α in the splenocytes was inhibited by anti-TLR2 antibody. Hence, the immune responses stimulated by the combination of HY8002 and HY7717 are associated with TLR2 activation. The preceding findings suggest that the combination of the HY8002 and HY7717 LAB strains could prove to be a beneficial and efficacious immunostimulant probiotic supplement. The combination of the two probiotic strains will be applied on the dairy foods including yogurt and cheese.

Lactic Acid Bacteria Improves Peyer's Patch Cell-Mediated Immunoglobulin A and Tight-Junction Expression in a Destructed Gut Microbial Environment

  • Kim, Sung Hwan;Jeung, Woonhee;Choi, Il-Dong;Jeong, Ji-Woong;Lee, Dong Eun;Huh, Chul-Sung;Kim, Geun-Bae;Hong, Seong Soo;Shim, Jae-Jung;Lee, Jung Lyoul;Sim, Jae-Hun;Ahn, Young-Tae
    • Journal of Microbiology and Biotechnology
    • /
    • 제26권6호
    • /
    • pp.1035-1045
    • /
    • 2016
  • To evaluate the effects of lactic acid bacteria (LAB) on Peyer's patch cells, mice were treated with a high dose of kanamycin to disturb the gut microbial environment. The overarching goal was to explore the potential of LAB for use as a dietary probiotic that buffers the negative consequences of antibiotic treatment. In vitro, LAB stimulated the production of immunoglobulin A (IgA) from isolated Peyer's patch cells. Inflammation-related genes (TNF-α, IL-1β, and IL-8) were up-regulated in Caco-2 cells stimulated with lipopolysaccharide (LPS), while tight-junction-related genes (ZO-1 and occludin) were down-regulated; the effects of LPS on inflammatory gene and tight-junction gene expression were reversed by treatment with LAB. Mice treated with a high dose of kanamycin showed increased serum IgE levels and decreases in serum IgA and fecal IgA levels; the number of Peyer's patch cells decreased with kanamycin treatment. However, subsequent LAB treatment was effective in reducing the serum IgE level and recovering the serum IgA and fecal IgA levels, as well as the number of Peyer's patch cells. In addition, ZO-1 and occludin mRNA levels were up-regulated in the ileum tissues of mice receiving LAB treatment. Lactic acid bacteria can enhance the intestinal immune system by improving the integrity of the intestinal barrier and increasing the production of IgA in Peyer's patches. Lactic acid bacteria should be considered a potential probiotic candidate for improving intestinal immunity, particularly in mitigating the negative consequences of antibiotic use.